Kilitch Drugs (India) Ltd (KILITCH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 189669, "name": "Kilitch Drugs", "stock_name": "Kilitch Drugs", "full_name": "Kilitch Drugs (India) Ltd", "name_url": "stocks-analysis/kilitch-drugs", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "154.53", "chg": 2.2, "chgp": "1.44%", "dir": 1, "prev_price": "152.33", "mcapval": "539.00 Cr", "mcap": "Micro Cap", "scripcode": 524500, "symbol": "KILITCH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE729D01010", "curr_date": "May 06", "curr_time": "", "bse_nse_vol": "23.79 k", "exc_status": "Active", "traded_date": "May 06, 2026", "traded_date_str": "2026 05 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Kilitch Drugs (India) Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-sell-3973056", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_mojoScore_3973056.png", "date": "2026-05-04 10:10:44", "description": "Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-3965345", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_technicaldot_3965345.png", "date": "2026-04-28 08:00:42", "description": "Kilitch Drugs (India) Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day gain of 2.29% to close at ₹154.20, the micro-cap pharmaceutical company continues to face headwinds as key technical indicators present a mixed picture, reflecting cautious investor sentiment amid broader market volatility." }, { "title": "Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-bearish-momentum-amid-technical-downturn-3963488", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_technicaldot_3963488.png", "date": "2026-04-27 08:00:19", "description": "Kilitch Drugs (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. The stock’s recent price action, combined with key technical indicators such as MACD, RSI, and moving averages, signals increasing downside pressure amid a challenging market environment." }, { "title": "Kilitch Drugs Gains 11.58%: 4 Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-gains-1158-4-key-factors-driving-the-weekly-rally-3963307", "imagepath": "", "date": "2026-04-26 14:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Apr:</strong> Stock opens at Rs.134.90, marginally down amid flat Sensex</p>\n <p><strong>21 Apr:</strong> Downgrade to Strong Sell announced; stock surges 5.86%</p>\n <p><strong>22 Apr:</strong> Valuation shifts to attractive; stock jumps 7.88%</p>\n <p><strong>23 Apr:</strong> Upgrade to Sell and technical momentum shift; intraday rally of 8.16%</p>\n <p><strong>24 Apr:</strong> Profit-taking leads to 5.75% decline; week closes at Rs.150.75</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-..." }, { "title": "Kilitch Drugs Upgraded to Sell: A Detailed Analysis of Quality, Valuation, Financial Trend, and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-sell-a-detailed-analysis-of-quality-valuation-financial-trend-and-technicals-3958355", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_mojoScore_3958355.png", "date": "2026-04-23 08:01:09", "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 22 April 2026, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing financial challenges. The pharmaceutical micro-cap’s recent price surge of 8.16% to ₹154.45 has contributed to this reassessment, signalling a shift in market sentiment and underlying fundamentals." }, { "title": "Kilitch Drugs (India) Ltd Sees Technical Momentum Shift Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3958238", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_technicaldot_3958238.png", "date": "2026-04-23 08:00:18", "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook, as reflected in recent market data and technical indicators. Despite a robust intraday price surge of 8.16%, the micro-cap pharmaceutical company continues to face mixed signals from key momentum and trend indicators, raising questions about its near-term trajectory amid broader sector and market dynamics." }, { "title": "Kilitch Drugs Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-downgraded-to-strong-sell-amid-mixed-financial-and-valuation-signals-3956782", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_mojoScore_3956782.png", "date": "2026-04-22 08:00:56", "description": "Kilitch Drugs (India) Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 21 Apr 2026, reflecting a complex interplay of valuation improvements, deteriorating financial trends, and weak quality metrics. Despite an attractive valuation profile, the company’s recent quarterly performance and technical indicators have raised concerns among analysts, prompting a reassessment of its market standing within the Pharmaceuticals & Biotechnology sector." }, { "title": "Kilitch Drugs Valuation Shifts to Attractive Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-attractive-amid-mixed-market-returns-3956483", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_valuationdot_3956483.png", "date": "2026-04-22 08:00:18", "description": "Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Strong Sell. This article analyses the evolving price attractiveness of the pharmaceutical micro-cap, contrasting its current valuation multiples with historical trends and peer benchmarks to provide a comprehensive view for investors." }, { "title": "Kilitch Drugs (India) Ltd Upgraded to Sell on Improved Valuation Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-upgraded-to-sell-on-improved-valuation-metrics-3945131", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_mojoScore_3945131.png", "date": "2026-04-14 08:01:46", "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026, driven primarily by a marked improvement in its valuation metrics. Despite ongoing financial headwinds and underperformance relative to the broader market, the company’s attractive price multiples and solid long-term growth prospects have prompted a reassessment of its investment appeal." } ], "total": 310, "sid": "189669", "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669" }, "announcements": [ { "details": "Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated December 09, 2019, titled \"Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 mn\".", "source": "NSE", "caption": "Kilitch Drugs (India) Limited - Press Release", "datetime": "09-Dec-2019" }, { "details": "Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on November 13, 2019.", "source": "NSE", "caption": "Kilitch Drugs (India) Limited - Outcome of Board Meeting", "datetime": "14-Nov-2019" }, { "details": " <table><tr><td>Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on September 19, 2019. </td></tr></table>", "source": "NSE", "caption": "Outcome of Board Meeting", "datetime": "19-Sep-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19", "dt": "2019-09-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26", "dt": "2026-03-24", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25", "dt": "2025-07-15", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

20 Apr: Stock opens at Rs.134.90, marginally down amid flat Sensex

21 Apr: Downgrade to Strong Sell announced; stock surges 5.86%

22 Apr: Valuation shifts to attractive; stock jumps 7.88%

23 Apr: Upgrade to Sell and technical momentum shift; intraday rally of 8.16%

24 Apr: Profit-taking leads to 5.75% decline; week closes at Rs.150.75

Week Open

Read full news article

Kilitch Drugs Upgraded to Sell: A Detailed Analysis of Quality, Valuation, Financial Trend, and Technicals

2026-04-23 08:01:09

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 22 April 2026, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing financial challenges. The pharmaceutical micro-cap’s recent price surge of 8.16% to ₹154.45 has contributed to this reassessment, signalling a shift in market sentiment and underlying fundamentals.

Read full news article

Kilitch Drugs (India) Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-04-23 08:00:18

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook, as reflected in recent market data and technical indicators. Despite a robust intraday price surge of 8.16%, the micro-cap pharmaceutical company continues to face mixed signals from key momentum and trend indicators, raising questions about its near-term trajectory amid broader sector and market dynamics.

Read full news article

Kilitch Drugs Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals

2026-04-22 08:00:56

Kilitch Drugs (India) Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 21 Apr 2026, reflecting a complex interplay of valuation improvements, deteriorating financial trends, and weak quality metrics. Despite an attractive valuation profile, the company’s recent quarterly performance and technical indicators have raised concerns among analysts, prompting a reassessment of its market standing within the Pharmaceuticals & Biotechnology sector.

Read full news article

Kilitch Drugs Valuation Shifts to Attractive Amid Mixed Market Returns

2026-04-22 08:00:18

Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Strong Sell. This article analyses the evolving price attractiveness of the pharmaceutical micro-cap, contrasting its current valuation multiples with historical trends and peer benchmarks to provide a comprehensive view for investors.

Read full news article

Kilitch Drugs (India) Ltd Upgraded to Sell on Improved Valuation Metrics

2026-04-14 08:01:46

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026, driven primarily by a marked improvement in its valuation metrics. Despite ongoing financial headwinds and underperformance relative to the broader market, the company’s attractive price multiples and solid long-term growth prospects have prompted a reassessment of its investment appeal.

Read full news article